Clinico-Molecular Risk Stratification in 284 Patients With Pre-Fibrotic and Overt Myelofibrosis

被引：0
|
作者：
Chang, Yu-Sung [1 ]
Wang, Yu-Hung [1 ,2 ]
Wei, Chao-Hung [3 ,4 ]
Lin, Chien-Chin [1 ,5 ]
Yuan, Chang-Tsu [6 ]
Tsai, Cheng-Hong [1 ,7 ]
Liu, Jia-Hau [8 ]
Ko, Bor-Sheng [8 ]
Yao, Ming [8 ]
Tien, Hwei-Fang [1 ,9 ]
Chou, Wen-Chien [1 ,5 ]
Hou, Hsin-An [1 ,10 ]
机构：
[1] Natl Taiwan Univ Hosp, Div Hematol, Dept Internal Med, Taipei, Taiwan
[2] Univ Manchester, Div Canc Sci, Epigenet Haematopoiesis Lab, Manchester, England
[3] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
[6] Natl Taiwan Univ, Dept Pathol, Canc Ctr, Taipei, Taiwan
[7] Natl Taiwan Univ Hosp, Dept Med Educ & Res, Yunlin Branch, Touliu, Yunlin, Taiwan
[8] Natl Taiwan Univ, Canc Ctr, Dept Hematol Oncol, Taipei, Taiwan
[9] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan
[10] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
MPN; myelofibrosis; genetic mutation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-239
引用
收藏
页码：S424 / S424
页数：1
相关论文
共 50 条
  • [1] Management of Pre-Fibrotic Primary Myelofibrosis
    Bose, Prithviraj
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S65 - S66
  • [2] Comments on pre-fibrotic myelofibrosis and how should it be managed
    Barbui, Tiziano
    Thiele, Juergen
    Gisslinger, Heinz
    Orazi, Attilio
    Vannucchi, Alessandro M.
    Gianelli, Umberto
    Beham-Schmid, Christine
    Tefferi, Ayalew
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (02) : 358 - 360
  • [3] What is pre-fibrotic myelofibrosis and how should it be managed in 2018?
    Curto-Garcia, Natalia
    Ianotto, Jean-Christophe
    Harrison, Claire N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (01) : 23 - 34
  • [4] Distinct Clinico-Molecular Arterial and Venous Thrombotic Scoring Systems for MPN Patients Risk Stratification
    Pasquer, Helene
    De Oliveira, Rafael Daltro
    Soret, Juliette
    Maslah, Nabih
    Zhao, Lin-Pierre
    Marcault, Clemence
    Cazaux, Marine
    Gauthier, Nicolas
    Verger, Emmanuelle
    Parquet, Nathalie
    Vainchenker, William
    Raffoux, Emmanuel
    Giraudier, Stephane
    Cassinat, Bruno
    Kiladjian, Jean-Jacques
    Benajiba, Lina
    BLOOD, 2022, 140
  • [5] Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis
    Cattaneo, Daniele
    Vener, Claudia
    Elli, Elena Maria
    Bucelli, Cristina
    Galli, Nicole
    Cavalca, Fabrizio
    Auteri, Giuseppe
    Vincelli, Donatella
    Martino, Bruno
    Gianelli, Umberto
    Palandri, Francesca
    Iurlo, Alessandra
    CANCERS, 2022, 14 (07)
  • [6] Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification
    Pasquer, Helene
    de Oliveira, Rafael Daltro
    Vasseur, Loic
    Soret-Dulphy, Juliette
    Maslah, Nabih
    Zhao, Lin-Pierre
    Marcault, Clemence
    Cazaux, Marine
    Gauthier, Nicolas
    Verger, Emmanuelle
    Parquet, Nathalie
    Vainchenker, William
    Raffoux, Emmanuel
    Ugo, Valerie
    Luque Paz, Damien
    Roy, Lydia
    Lambert, Wayne-Corentin
    Ianotto, Jean-Christophe
    Lippert, Eric
    Giraudier, Stephane
    Cassinat, Bruno
    Kiladjian, Jean-Jacques
    Benajiba, Lina
    LEUKEMIA, 2024, 38 (02) : 326 - 339
  • [7] Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification
    Hélène Pasquer
    Rafael Daltro de Oliveira
    Loic Vasseur
    Juliette Soret-Dulphy
    Nabih Maslah
    Lin-Pierre Zhao
    Clémence Marcault
    Marine Cazaux
    Nicolas Gauthier
    Emmanuelle Verger
    Nathalie Parquet
    William Vainchenker
    Emmanuel Raffoux
    Valérie Ugo
    Damien Luque Paz
    Lydia Roy
    Wayne-Corentin Lambert
    Jean-Christophe Ianotto
    Eric Lippert
    Stéphane Giraudier
    Bruno Cassinat
    Jean-Jacques Kiladjian
    Lina Benajiba
    Leukemia, 2024, 38 : 326 - 339
  • [8] Validation of the International Prognostic Score for Thrombosis in Essential Thrombocythemia (IPSET) in Patients with Pre-Fibrotic Primary Myelofibrosis
    Guglielmelli, Paola
    Carobbio, Alessandra
    Rumi, Elisa
    De Stefano, Valerio
    Mannelli, Lara
    Mannelli, Francesco
    Rotunno, Giada
    Coltro, Giacomo
    Betti, Silvia
    Cavalloni, Chiara
    Finazzi, Maria Chiara
    Thiele, Juergen
    Cazzola, Mario
    Vannucchi, Alessandro M.
    Barbui, Tiziano
    BLOOD, 2019, 134
  • [9] Efficacy and Safety of Ropeginterferon Alfa-2b for Pre-Fibrotic Primary Myelofibrosis and DIPSS Low/Intermediate-1 Risk Myelofibrosis
    Gill, Harinder
    Au, Lester
    Yim, Rita
    Chin, Lynn
    Li, Vivian
    Lee, Paul
    Leung, Garret Mk
    Lee, Carmen
    Wu, Tony Kwun Yat
    Ngai, Cheong
    Ho, Ryan
    Sin, Albert Chun Fung
    Hou, Hsin-An
    Chen, Chih-Cheng
    Kwong, Yok-Lam
    BLOOD, 2022, 140 : 1522 - 1522
  • [10] Clinical and Genetic Features By Next-Generation Sequencing and RNA Sequencing in Pre-Fibrotic Primary Myelofibrosis Patients
    Hu, Shiwei
    Yang, Xiudi
    Zhu, Jingjing
    Huang, Jian
    BLOOD, 2023, 142
12345